Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Hee Cho

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
American Journal of Clinical Oncology|February 10, 2010
Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancerHyun-Jeong Shim, Sang-Hee Cho, Jun-Eul Hwang, et al.
Journal of Korean Medical Science|August 13, 2002
A case of secondary myocardial lymphoma presenting with ventricular tachycardiaJeong-Gwan Cho, Young-Keun Ahn, Sang-Hee Cho, et al.
BMC Cancer|November 23, 2011
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancerJun-Eul Hwang, Ha-Na Kim, Dae-Eun Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancerKa-Rham Kim, Hyun-Jeong Shim, Jun-Eul Hwang, et al.
Annals of Hematology|November 13, 2008
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphomaDeok-Hwan Yang, Jung-Joon Min, Yong Yeon Jeong, et al.
Journal of Korean Medical Science|April 7, 2011
VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinomaMee Sun Yoon, Taek-Keun Nam, Ji-Shin Lee, et al.
International Journal of Hematology|May 28, 2009
Polymyositis and myocarditis after donor lymphocyte infusionJae-Sook Ahn, Sang-Hee Cho, Yeo-Kyeoung Kim, et al.
Cancer Communications (London, England)|July 29, 2024
Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesisDae-Hwan Kim, Minjeong Sung, Myong-Suk Park, et al.
Cancer Research and Treatment|July 12, 2019
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled TrialWonyoung Choi, Jong Gwang Kim, Seung-Hoon Beom, et al.
Cancer Letters|December 10, 2017
TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinomaWoo-Kyun Bae, Chang-Soo Hong, Mi-Ra Park, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
American Journal of Clinical Oncology|February 10, 2010
Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancerHyun-Jeong Shim, Sang-Hee Cho, Jun-Eul Hwang, et al.
Journal of Korean Medical Science|August 13, 2002
A case of secondary myocardial lymphoma presenting with ventricular tachycardiaJeong-Gwan Cho, Young-Keun Ahn, Sang-Hee Cho, et al.
BMC Cancer|November 23, 2011
Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancerJun-Eul Hwang, Ha-Na Kim, Dae-Eun Kim, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancerKa-Rham Kim, Hyun-Jeong Shim, Jun-Eul Hwang, et al.
Annals of Hematology|November 13, 2008
The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphomaDeok-Hwan Yang, Jung-Joon Min, Yong Yeon Jeong, et al.
Journal of Korean Medical Science|April 7, 2011
VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinomaMee Sun Yoon, Taek-Keun Nam, Ji-Shin Lee, et al.
International Journal of Hematology|May 28, 2009
Polymyositis and myocarditis after donor lymphocyte infusionJae-Sook Ahn, Sang-Hee Cho, Yeo-Kyeoung Kim, et al.
Cancer Communications (London, England)|July 29, 2024
Galectin 3-binding protein (LGALS3BP) depletion attenuates hepatic fibrosis by reducing transforming growth factor-β1 (TGF-β1) availability and inhibits hepatocarcinogenesisDae-Hwan Kim, Minjeong Sung, Myong-Suk Park, et al.
Cancer Research and Treatment|July 12, 2019
Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled TrialWonyoung Choi, Jong Gwang Kim, Seung-Hoon Beom, et al.
Cancer Letters|December 10, 2017
TAp73 inhibits cell invasion and migration by directly activating KAI1 expression in colorectal carcinomaWoo-Kyun Bae, Chang-Soo Hong, Mi-Ra Park, et al.
Pageof 15